by Agilent Technologies
Polaris HPLC Columns
Performs Well Under Aqueous Conditions
In areas like drug discovery where target compounds are increasingly polar, it is critical to have a reversed-phase column that performs well under aqueous conditions. Retention is critical, but cannot come with troublesome secondary interactions. Likewise, phase collapse and shifting retention times need to be avoided. The answer is our Polaris line of polar modified columns.
| Vendor | Agilent Technologies | Pore size | 180 |
| Brand | Agilent Polaris | Surface Area | 200 |
| Modifification | Silica/C8 | Carbon Load, % | 7.4 |
| Mode | Reversed-Phase | Endcapped | Yes |
| Particle Size | Operating Temperature | 60 | |
| Length | pH stability to | 10.0 | |
| Internal Diameter |
| Vendor | Brand | Mode | Modification | Int. diam. | Length | Particles | Pores | Price |
|---|---|---|---|---|---|---|---|---|
| Welch Materials | Topsil C8 | Reversed-Phase | Silica/C8 | 4.0 mm | 200 mm | 3.0 μm | 150 Å | On request |
| Orochem | Matrix C8 | Reversed-Phase | Silica/C8 | 4.6 mm | 250 mm | 5.0 μm | 100 Å | On request |
| Agilent Technologies | ZORBAX Stablebond | Reversed-Phase | Silica/C8 | 3.0 mm | 250 mm | 5.0 μm | 80 Å | On request |
| Fortis Technologies | Fortis C8 | Reversed-Phase | Silica/C8 | 4.6 mm | 100 mm | 3.0 μm | — | On request |
| Merck | LiChrosorb® | Reversed-Phase | Silica/C8 | 4.0 mm | 125 mm | 5.0 μm | 100 Å | On request |
| ES Industries | Chromegabond 300 MC-8 | Reversed-Phase | Silica/C8 | 4.6 mm | 250 mm | 5.0 μm | 300 Å | On request |
| ACE | ACE C8-300 | Reversed-Phase | Silica/C8 | 1.0 mm | 75 mm | 3.0 μm | 300 Å | On request |
| WATERS | Spherisorb C8 | Reversed-Phase | Silica/C8 | 4.6 mm | 100 mm | 5.0 μm | 80 Å | On request |
No customer reviews yet. Be the first to share your experience!
Reach thousands of researchers worldwide. Fill in your details and our team will contact you shortly.
